Glycated Hemoglobin as a Marker for Predicting Outcomes of Patients With Stroke (Ischemic and Hemorrhagic): A Systematic Review and Meta-Analysis

被引:13
作者
Bao, Yaya [1 ]
Gu, Dadong [2 ]
机构
[1] Shaoxing Univ, Med Coll, Shaoxing, Peoples R China
[2] Shaoxing Univ, Zhuji Affiliated Hosp, Dept Neurol, Zhuji, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2021年 / 12卷
关键词
glycated hemoglobin; stroke; glycemic control; ischemic stroke; meta-analysis;
D O I
10.3389/fneur.2021.642899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Glycated hemoglobin (HbA1c) has emerged as a useful biochemical marker reflecting the average glycemic control over the last 3 months, and the values are not affected by short-term transient changes in blood glucose levels. However, its prognostic value in the acute neurological conditions such as stroke is still not well-established. The present meta-analysis was conducted to assess the relationship of HbA1c with outcomes such as mortality, early neurological complications, and functional dependence in stroke patients. Methods: A systematic search was conducted for the PubMed, Scopus, and Google Scholar databases. Studies, either retrospective or prospective in design that examined the relationship between HbA1c with outcomes of interest and presented the strength of association in the form of adjusted odds ratio/hazard ratios were included in the review. Statistical analysis was done using STATA version 13.0. Results: A total of 22 studies (15 studies on acute ischemic stroke and seven studies on hemorrhagic stroke) were included in the meta-analysis. For patients with acute ischemic stroke, each unit increase in HbA1c was found to be associated with an increased risk of mortality within 1 year, increased risk of poor functional outcome at 3 months, and an increased risk of symptomatic intracranial hemorrhage (sICH) within 24 h of admission. In those with HbA1c >= 6.5%, there was an increased risk of mortality within 1 year of admission, increased risk of poor functional outcomes at 3 and 12 months as well as an increased risk of symptomatic intracranial hemorrhage (sICH) within 24 h of admission. In patients with hemorrhagic stroke, each unit increase in HbA1c was found to be associated with increased risk of poor functional outcome within the first 3 months from the time of admission for stroke. In those with HbA1c >= 6.5%, there was an increased risk of poor functional outcome at 12 months. Conclusions: The findings indicate that glycated hemoglobin (HbA1c) could serve as a useful marker to predict the outcomes in patients with stroke and aid in the implementation of adequate preventive management strategies at the earliest.
引用
收藏
页数:16
相关论文
共 47 条
  • [1] [Anonymous], 2017, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
  • [2] Beckman JA, 2013, EUR HEART J, V34, P2444, DOI 10.1093/eurheartj/eht142
  • [3] A Study of Plasma Fibrinogen Level in Type-2 Diabetes Mellitus and its Relation to Glycemic Control
    Bembde, Archana Sachin
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (02) : 105 - 108
  • [4] HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion
    Choi, Kang-Ho
    Kim, Ja-Hae
    Kang, Kyung-Wook
    Kim, Joon-Tae
    Choi, Seong-Min
    Lee, Seung-Han
    Park, Man-Seok
    Kim, Byeong-Chae
    Kim, Myeong-Kyu
    Cho, Ki-Hyun
    [J]. STROKE, 2019, 50 (01) : 119 - 126
  • [5] The role of HbA1c in the diagnosis of diabetes mellitus in Australia
    d'Emden, Michael C.
    Shaw, Jonathan E.
    Colman, Peter G.
    Colagiuri, Stephen
    Twigg, Stephen M.
    Jones, Graham R. D.
    Goodall, Ian
    Schneider, Hans G.
    Cheung, N. Wah
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (04) : 220 - 221
  • [6] A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients
    Dandapat, Sudeepta
    Siddiqui, Fazeel M.
    Fonarow, Gregg C.
    Bhatt, Deepak L.
    Xu, Haolin
    Matsouaka, Roland
    Heidenreich, Paul A.
    Xian, Ying
    Schwamm, Lee H.
    Smith, Eric E.
    [J]. HELIYON, 2019, 5 (05)
  • [7] Glycated hemoglobin (HbA1c) and outcome following endovascular thrombectomy for ischemic stroke
    Diprose, William K.
    Wang, Michael T. M.
    McFetridge, Andrew
    Sutcliffe, James
    Barber, P. Alan
    [J]. JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (01) : 30 - 32
  • [8] The Disparity in Long-Term Survival after a First Stroke in Patients with and without Diabetes Persists: The Northern Sweden MONICA Study
    Eriksson, Marie
    Carlberg, Bo
    Eliasson, Mats
    [J]. CEREBROVASCULAR DISEASES, 2012, 34 (02) : 153 - 160
  • [9] Association between Elevated Hemoglobin A1c Levels and the Outcomes of Patients with Small-Artery Occlusion: A Hospital-Based Study
    Gao, Yuan
    Jiang, Lihong
    Wang, Hui
    Yu, Changshen
    Wang, Wanjun
    Liu, Shoufeng
    Gao, Chunlin
    Tong, Xiaoguang
    Wang, Jinhuan
    Jin, Yi
    Wu, Jialing
    [J]. PLOS ONE, 2016, 11 (08):
  • [10] The Role of Prestroke Glycemic Control on Severity and Outcome of Acute Ischemic Stroke
    Hjalmarsson, Clara
    Manhem, Karin
    Bokemark, Lena
    Andersson, Bjorn
    [J]. STROKE RESEARCH AND TREATMENT, 2014, 2014